Live Breaking News & Updates on Frontier Medicines Corporation

Stay updated with breaking news from Frontier medicines corporation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Frontier Medicines Presents New Data for First-In-Class Dual ON+OFF KRAS G12C Inhibitor FMC-376 at the AACR Annual Meeting

Frontier Medicines Presents New Data for First-In-Class Dual ON+OFF KRAS G12C Inhibitor FMC-376 at the AACR Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , San Diego , Andrew Krivoshik , Kevin Webster , Corporate Affairs , American Association For Cancer Research , Frontier Medicines Corporation , Medicines Corporation , American Association , Cancer Research , Annual Meeting , Medicines Contact ,

Frontier Medicines Presents New Data for First-In-Class Dual ON+OFF KRAS G12C Inhibitor FMC-376 at the AACR Annual Meeting

- Pre-clinical results demonstrate the combination of FMC-376 with PD-1 immunotherapy increases survival and response rates compared to PD-1 alone. ....

United States , San Diego , Kevin Webster , Andrew Krivoshik , Frontier Medicines Corporation , American Association For Cancer Research , Corporate Affairs , Medicines Corporation , American Association , Cancer Research , Annual Meeting , Medicines Contact ,

Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline - Galapagos (NASDAQ:GLPG)

- First participant dosed in Phase 1/2 PROSPER trial of FMC-376 in KRASG12C Cancers - FMC-376 is a first-in-class direct dual inhibitor of ON+OFF KRASG12C- FMC-376 has the potential to transform patient outcomes with ....

United States , Paul Stoffel , Paul Stoffels , Chris Varma , Corporate Affairs , Frontier Medicines Corporation , Deerfield Management Company , Medicines Corporation , Droia Ventures , Medicines Contact ,

STORM Therapeutics Appoints Marguerite Hutchinson, J.D., as Chief Business Officer

STORM Therapeutics Appoints Marguerite Hutchinson, J.D., as Chief Business Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Marguerite Hutchinson , Jerry Mcmahon , Harvard University , Counsel Of Plexxikon Inc , Seroba Life Sciences , Therapeutics Ltd , University Of San Diego School Law , Ip Group , Frontier Medicines Corporation , Utokyo Innovation Platform Co Ltd , Fast Track Initiative , Taiho Ventures , Cambridge Innovation Capital , Daiichi Sankyo Group , Cancer Research United Kingdom , Chief Business , Chief Operating Officer , General Counsel , Plexxikon Inc , Cancer Research United , Cogent Biosciences , Chief Executive Officer , Chief Business Officer , Tatara Therapeutics , San Diego School ,

Frontier Medicines Presents New Preclinical Data on its Development Candidate, FMC-376, a Dual KRASG12C Inhibitor, at the 2023 AACR Annual Meeting

Frontier Medicines Presents New Preclinical Data on its Development Candidate, FMC-376, a Dual KRASG12C Inhibitor, at the 2023 AACR Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Chris Varma , Frontier Medicines Corporation , Corporate Affairs , American Association For Cancer Research , Medicines Corporation , Cancer Research , Annual Meeting , Investigational New Drug , Frontier Medicinesfrontier Medicines , Media Relations Contact ,